Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires 2,029 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) by 6.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 33,031 shares of the medical equipment provider’s stock after acquiring an additional 2,029 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Lantheus were worth $2,772,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in Lantheus by 4.4% during the 3rd quarter. Vanguard Group Inc. now owns 7,765,120 shares of the medical equipment provider’s stock worth $546,121,000 after buying an additional 326,396 shares during the period. Alliancebernstein L.P. increased its position in Lantheus by 18.1% during the 4th quarter. Alliancebernstein L.P. now owns 3,193,302 shares of the medical equipment provider’s stock worth $162,731,000 after buying an additional 489,203 shares during the period. State Street Corp increased its position in Lantheus by 0.3% during the 2nd quarter. State Street Corp now owns 2,393,559 shares of the medical equipment provider’s stock worth $158,047,000 after buying an additional 7,307 shares during the period. Hood River Capital Management LLC increased its position in Lantheus by 4.0% during the 1st quarter. Hood River Capital Management LLC now owns 1,633,626 shares of the medical equipment provider’s stock worth $134,872,000 after buying an additional 62,827 shares during the period. Finally, Geode Capital Management LLC increased its position in Lantheus by 3.6% during the 1st quarter. Geode Capital Management LLC now owns 1,345,272 shares of the medical equipment provider’s stock worth $111,203,000 after buying an additional 46,873 shares during the period. Institutional investors own 99.06% of the company’s stock.

Lantheus Stock Performance

NASDAQ:LNTH opened at $69.12 on Tuesday. The stock’s 50-day simple moving average is $66.53 and its 200 day simple moving average is $77.17. The firm has a market capitalization of $4.73 billion, a PE ratio of 48.40 and a beta of 0.66. The company has a quick ratio of 5.05, a current ratio of 5.37 and a debt-to-equity ratio of 0.80. Lantheus Holdings, Inc. has a twelve month low of $47.46 and a twelve month high of $100.85.

Analyst Ratings Changes

Several analysts have recently issued reports on LNTH shares. StockNews.com raised Lantheus from a “hold” rating to a “buy” rating in a report on Monday, November 6th. Truist Financial reissued a “buy” rating and set a $110.00 target price on shares of Lantheus in a report on Wednesday, October 4th. JMP Securities reduced their target price on Lantheus from $130.00 to $100.00 and set a “market outperform” rating on the stock in a report on Friday, November 3rd. Mizuho reissued a “buy” rating and set a $125.00 target price on shares of Lantheus in a report on Wednesday, October 4th. Finally, TheStreet raised Lantheus from a “c” rating to a “b-” rating in a report on Wednesday, August 9th. Seven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $115.00.

Insider Activity at Lantheus

In related news, CEO Mary Anne Heino sold 11,780 shares of the firm’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $63.72, for a total value of $750,621.60. Following the sale, the chief executive officer now directly owns 317,687 shares of the company’s stock, valued at $20,243,015.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Lantheus news, insider Daniel Niedzwiecki sold 2,846 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $66.43, for a total value of $189,059.78. Following the completion of the transaction, the insider now directly owns 66,295 shares in the company, valued at $4,403,976.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Mary Anne Heino sold 11,780 shares of the stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $63.72, for a total value of $750,621.60. Following the completion of the transaction, the chief executive officer now owns 317,687 shares of the company’s stock, valued at $20,243,015.64. The disclosure for this sale can be found here. Insiders have sold 16,467 shares of company stock valued at $1,063,299 over the last ninety days. 1.50% of the stock is owned by corporate insiders.

Lantheus Company Profile

Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; and Cardiolite, an injectable Tc-99m-labeled imaging agent.